标题
Targeting the histone orthography of cancer: drugs for writers, erasers and readers
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 11, Pages 2716-2732
出版商
Wiley
发表日期
2014-07-16
DOI
10.1111/bph.12844
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors
- (2014) P. A. Cassier et al. ANNALS OF ONCOLOGY
- Optimizing outcomes with azacitidine: recommendations from Canadian centres of excellence
- (2014) R.A. Wells et al. Current Oncology
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo
- (2014) Gautam Sethi et al. Molecular Cancer
- Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic stem cell DNA
- (2014) Toni Pfaffeneder et al. Nature Chemical Biology
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- A Novel Curcumin Analog (H-4073) Enhances the Therapeutic Efficacy of Cisplatin Treatment in Head and Neck Cancer
- (2014) Bhavna Kumar et al. PLoS One
- Study to Evaluate Molecular Mechanics behind Synergistic Chemo-Preventive Effects of Curcumin and Resveratrol during Lung Carcinogenesis
- (2014) Anshoo Malhotra et al. PLoS One
- An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
- (2013) Kyle D. Konze et al. ACS Chemical Biology
- Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells
- (2013) Ziyan Lu et al. ANTI-CANCER DRUGS
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
- (2013) A. J. Deshpande et al. BLOOD
- Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma
- (2013) J. E. Amengual et al. BLOOD
- Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762
- (2013) A. Chaidos et al. BLOOD
- The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition
- (2013) Michael Amatangelo et al. CELL CYCLE
- A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors
- (2013) B. Venugopal et al. CLINICAL CANCER RESEARCH
- Cancer genomics identifies disrupted epigenetic genes
- (2013) Laia Simó-Riudalbas et al. HUMAN GENETICS
- In focus: MLL-rearranged leukemia
- (2013) J de Boer et al. LEUKEMIA
- Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain
- (2013) Lindsey I James et al. Nature Chemical Biology
- Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases
- (2013) Fanny L Cherblanc et al. Nature Chemical Biology
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis
- (2013) M Rodriguez-Paredes et al. ONCOGENE
- Quercetin Enhances the Antitumor Activity of Trichostatin A through Upregulation of p53 Protein Expression In Vitro and In Vivo
- (2013) Shu-Ting Chan et al. PLoS One
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
- (2013) Hanne Fredly et al. Clinical Epigenetics
- A Small-Molecule Probe of the Histone Methyltransferase G9a Induces Cellular Senescence in Pancreatic Adenocarcinoma
- (2012) Yuan Yuan et al. ACS Chemical Biology
- CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells
- (2012) Ke Gong et al. BIOCHEMICAL JOURNAL
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors
- (2012) U. Banerji et al. CLINICAL CANCER RESEARCH
- Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor
- (2012) Dominica Willmann et al. INTERNATIONAL JOURNAL OF CANCER
- Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
- (2012) A Vilas-Zornoza et al. LEUKEMIA
- GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia
- (2012) T Holmlund et al. LEUKEMIA
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
- (2012) Laurens Kruidenier et al. NATURE
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
- (2012) Tino Schenk et al. NATURE MEDICINE
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic Events That Shape the Cancer Epigenome
- (2012) R. J. H. Ryan et al. SCIENCE
- Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group
- (2012) Chris J. Vickers et al. ACS Medicinal Chemistry Letters
- Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
- (2012) Wenyu Yu et al. Nature Communications
- Emerging Roles of Anacardic Acid and Its Derivatives: A Pharmacological Overview
- (2011) Mahadevappa Hemshekhar et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Inhibitors of histone demethylases
- (2011) Brian Lohse et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Peripheral T-cell lymphoma
- (2011) F. M. Foss et al. BLOOD
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia
- (2011) J. He et al. BLOOD
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
- (2011) E. A. Stronach et al. CANCER RESEARCH
- Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties
- (2011) J. Wang et al. CANCER RESEARCH
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
- (2011) Masashi Takawa et al. CANCER SCIENCE
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Chemogenetic Analysis of Human Protein Methyltransferases
- (2011) Victoria M. Richon et al. Chemical Biology & Drug Design
- Inhibition of Histone Demethylases by 4-Carboxy-2,2′-Bipyridyl Compounds
- (2011) Kai-Hsuan Chang et al. ChemMedChem
- Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation
- (2011) H. Wu et al. GENES & DEVELOPMENT
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Hypomethylating Agents and Other Novel Strategies in Myelodysplastic Syndromes
- (2011) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- Small-Molecule Ligands of Methyl-Lysine Binding Proteins
- (2011) J. Martin Herold et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
- (2011) Anas Younes et al. LANCET ONCOLOGY
- Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1
- (2011) H Chaib et al. LEUKEMIA
- Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
- (2011) F. R. Santer et al. MOLECULAR CANCER THERAPEUTICS
- Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer
- (2011) Eric C. Kauffman et al. MOLECULAR CARCINOGENESIS
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
- (2011) Craig J. Ceol et al. NATURE
- A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
- (2011) Masoud Vedadi et al. Nature Chemical Biology
- Analysis of the coding genome of diffuse large B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE GENETICS
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Sirtuin chemical mechanisms
- (2010) Anthony A. Sauve BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides
- (2010) Jerome C. Bressi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
- (2010) Nina Wagener et al. BMC CANCER
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
- (2010) Erin M. Bowers et al. CHEMISTRY & BIOLOGY
- Structural studies on human 2-oxoglutarate dependent oxygenases
- (2010) Michael A McDonough et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
- (2010) Shinya Hayami et al. INTERNATIONAL JOURNAL OF CANCER
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor
- (2010) David Moffat et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines.
- (2010) Feng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma
- (2010) Sundar Jagannath et al. LEUKEMIA RESEARCH
- A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
- (2010) Jaime Coronel et al. MEDICAL ONCOLOGY
- Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway
- (2010) Shinya Hayami et al. Molecular Cancer
- SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
- (2010) V. Novotny-Diermayr et al. MOLECULAR CANCER THERAPEUTICS
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
- (2010) Gorica Nikoloski et al. NATURE GENETICS
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation
- (2010) Sohail Malik et al. NATURE REVIEWS GENETICS
- Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors
- (2010) Oliver N. F. King et al. PLoS One
- Fast signals and slow marks: the dynamics of histone modifications
- (2010) Teresa K. Barth et al. TRENDS IN BIOCHEMICAL SCIENCES
- Polycomb group protein-mediated repression of transcription
- (2010) Lluís Morey et al. TRENDS IN BIOCHEMICAL SCIENCES
- Oxidation of amines by flavoproteins
- (2009) Paul F. Fitzpatrick ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis
- (2009) Aron Gyuris et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
- (2009) J. Arts et al. CLINICAL CANCER RESEARCH
- Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes
- (2009) Y. Huang et al. CLINICAL CANCER RESEARCH
- An operational definition of epigenetics
- (2009) S. L. Berger et al. GENES & DEVELOPMENT
- In VivoResidue-specific Histone Methylation Dynamics
- (2009) Barry M. Zee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
- (2009) Yanqi Chang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
- (2009) G Liu et al. ONCOGENE
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- What controls nucleosome positions?
- (2009) Eran Segal et al. TRENDS IN GENETICS
- Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60
- (2008) Jiang Wu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors
- (2008) Lillian L. Siu et al. JOURNAL OF CLINICAL ONCOLOGY
- Demystified molecular pathology of NUT midline carcinomas
- (2008) C. A. French JOURNAL OF CLINICAL PATHOLOGY
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
- The structural basis of protein acetylation by the p300/CBP transcriptional coactivator
- (2008) Xin Liu et al. NATURE
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now